Warning Letter Roundup & Recap – August 2022
Executive Summary
The US FDA handed warning letters to three manufacturers last month, including a COVID-19 test company as well as two infusion firms under the same ownership.
You may also be interested in...
EU Pharma Wants Regulators’ Help To Simplify Digital Endpoints Landscape
The European pharmaceutical industry federation, EFPIA, says its member companies are not looking for shortcuts to develop and validate digital biomarkers, but want help from regulators to create the right evidence.
Partnerships Are Key To Sustainable mRNA Vaccine Production In LMICs
Low- and middle-income countries need to have the know-how, capability and capacity to produce mRNA vaccines, from concept, design and testing through to manufacturing and registration, a conference heard this week.
Early Advice Could Help Companies Maintain EU Conditional Marketing Authorizations
The number of conditional marketing authorization non-renewals could increase.